Dataset
Risultati della ricerca
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497.v1, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497/1
Dataset
-
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Tursi, A. (Creator), Mocci, G. (Creator), Scaldaferri, F. (Creator), Napolitano, D. (Creator), Maresca, R. (Creator), Pugliese, D. (Creator), Semprucci, G. (Creator), Savarino, E. (Creator), Cuomo, A. (Creator), Donnarumma, L. (Creator), Bodini, G. (Creator), Pasta, A. (Creator), Maconi, G. (Creator), Cataletti, G. (Creator), Pranzo, G. (Creator), Rodinò, S. (Creator), Sebkova, L. (Creator), Costa, F. (Creator), Ferronato, A. (Creator), Gaiani, F. (Creator), Marzo, M. (Creator), Luppino, I. (Creator), Fabiano, G. (Creator), Paese, P. (Creator), Elisei, W. (Creator), Monterubbianesi, R. (Creator), Faggiani, R. (Creator), Grossi, L. (Creator), Serio, M. (Creator), Scarcelli, A. (Creator), Lorenzetti, R. (Creator), Allegretta, L. (Creator), Chiri, S. (Creator), Grasso, G. (Creator), Antonelli, E. (Creator), Bassotti, G. (Creator), Spagnuolo, R. (Creator), Luzza, F. (Creator), Fanigliulo, L. (Creator), Rocco, G. (Creator), Sacchi, C. (Creator), Zampaletta, C. (Creator), Rocchi, C. (Creator), Bolognini, L. (Creator), Bendia, E. (Creator), Bianco, M. A. (Creator), Capone, P. (Creator), Meucci, C. (Creator), Colucci, R. (Creator), Tonti, P. (Creator), Neve, V. (Creator), Della Valle, N. (Creator), Felice, C. (Creator), Pica, R. (Creator), Cocco, A. (Creator), Forti, G. (Creator), Onidi, F. M. (Creator), Usai Satta, P. (Contributor), Checchin, D. (Creator), Gravina, A. G. (Creator), Pellegrino, R. (Creator), Picchio, M. (Creator) & Papa, A. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.25039971, https://tandf.figshare.com/articles/dataset/Ustekinumab_safety_and_effectiveness_in_patients_with_ulcerative_colitis_results_from_a_large_real-life_study/25039971
Dataset
-
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Tursi, A. (Creator), Mocci, G. (Creator), Scaldaferri, F. (Creator), Napolitano, D. (Creator), Maresca, R. (Creator), Pugliese, D. (Creator), Semprucci, G. (Creator), Savarino, E. (Creator), Cuomo, A. (Creator), Donnarumma, L. (Creator), Bodini, G. (Creator), Pasta, A. (Creator), Maconi, G. (Creator), Cataletti, G. (Creator), Pranzo, G. (Creator), Rodinò, S. (Creator), Sebkova, L. (Creator), Costa, F. (Creator), Ferronato, A. (Creator), Gaiani, F. (Creator), Marzo, M. (Creator), Luppino, I. (Creator), Fabiano, G. (Creator), Paese, P. (Creator), Elisei, W. (Creator), Monterubbianesi, R. (Creator), Faggiani, R. (Creator), Grossi, L. (Creator), Serio, M. (Creator), Scarcelli, A. (Creator), Lorenzetti, R. (Creator), Allegretta, L. (Creator), Chiri, S. (Creator), Grasso, G. (Creator), Antonelli, E. (Creator), Bassotti, G. (Creator), Spagnuolo, R. (Creator), Luzza, F. (Creator), Fanigliulo, L. (Creator), Rocco, G. (Creator), Sacchi, C. (Creator), Zampaletta, C. (Creator), Rocchi, C. (Creator), Bolognini, L. (Creator), Bendia, E. (Creator), Bianco, M. A. (Creator), Capone, P. (Creator), Meucci, C. (Creator), Colucci, R. (Creator), Tonti, P. (Creator), Neve, V. (Creator), Della Valle, N. (Creator), Felice, C. (Creator), Pica, R. (Creator), Cocco, A. (Creator), Forti, G. (Creator), Onidi, F. M. (Creator), Usai Satta, P. (Contributor), Checchin, D. (Creator), Gravina, A. G. (Creator), Pellegrino, R. (Creator), Picchio, M. (Creator) & Papa, A. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.25039971.v1, https://tandf.figshare.com/articles/dataset/Ustekinumab_safety_and_effectiveness_in_patients_with_ulcerative_colitis_results_from_a_large_real-life_study/25039971/1
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497.v1, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497/1
Dataset